Target identification and validation through genetics

Drug Discovery Today: TARGETS

Volumn 3, Issue 5, 2004, Pages 183-190

  Allen, Maxine J ^a   Carey, Alisoun H ^a  

^a Oxagen Ltd   (United Kingdom)

Author keywords

association; Biochemistry; case control; complex trait; Drug Discovery; drug target; genetics; Genetics; GPCR; haplotype tagging; linkage disequilibrium; Pharmacology; SNP

Indexed keywords

DRUG TARGETING; GENE TARGETING; GENETICS; MOLECULAR CLONING; REVIEW; VALIDATION PROCESS;

EID: 4644289161     PISSN: 17418372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1741-8372(04)02450-8     Document Type: Review

References (50)

1. Goldstein D.B., et al. Pharmacogenetics goes genomic. Nat. Rev. Genet. 4:2003;937-947
2. Botstein D., Risch N. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat. Genet. 33:(Suppl):2003;228-237
3. Martin E.R., et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am. J. Hum. Genet. 67:2000;383-394
4. Horikawa Y., et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26:2000;163-175
5. Hugot J.P., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603
6. Allen M., et al. Positional cloning of a novel gene influencing asthma from chromosome 2q14. Nat. Genet. 35:2003;258-263
7. Helgadottir A., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36:2004;233-239
8. Laitinen T., et al. Characterization of a common susceptibility locus for asthma-related traits. Science. 304:2004;300-304
9. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921
10. Sachidanandam R., et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 409:2001;928-933
11. Venter J.C., et al. The sequence of the human genome. Science. 291:2001;1304-1351
12. Wall J.D., Pritchard J.K. Haplotype blocks and linkage disequilibrium in the human genome. Nat. Rev. Genet. 4:2003;587-597
13. Gabriel S.B., et al. The structure of haplotype blocks in the human genome. Science. 296:2002;2225-2229
14. Jeffreys A.J., et al. Intensely punctate meiotic recombination in the class II region of the major histocompatibility complex. Nat. Genet. 29:2001;217-222
15. Ardlie K.G., et al. Patterns of linkage disequilibrium in the human genome. Nat. Rev. Genet. 3:2002;299-309
16. Cardon L.R., Abecasis G.R. Using haplotype blocks to map human complex trait loci. Trends Genet. 19:2003;135-140
17. Daly M.J., et al. High-resolution haplotype structure in the human genome. Nat. Genet. 29:2001;229-232
18. Zhang K., et al. Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet. 71:2002;1386-1394
19. Ke X., Cardon L.R. Efficient selective screening of haplotype tag SNPs. Bioinformatics. 19:2003;287-288
20. Carlson C.S., et al. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74:2004;106-120
21. Stram D.O., et al. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum. Hered. 55:2003;27-36
22. Zondervan K.T., Cardon L.R. The complex interplay among factors that influence allelic association. Nat. Rev. Genet. 5:2004;89-100
23. The International HapMap Consortium. The International HapMap Project. Nature. 426:2003;789-796
24. Risch N.J. Searching for genetic determinants in the new millennium. Nature. 405:2000;847-856
25. Falush D., et al. Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics. 164:2003;1567-1587
26. Pritchard J.K., et al. Inference of population structure using multilocus genotype data. Genetics. 155:2000;945-959
27. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat. Rev. Genet. 2:2001;91-99
28. Devlin B., et al. False discovery or missed discovery? Heredity. 91:2003;537-538
29. Sabatti C., et al. False discovery rate in linkage and association genome screens for complex disorders. Genetics. 164:2003;829-833
30. Abecasis G.R., et al. The impact of genotyping error on family-based analysis of quantitative traits. Eur. J. Hum. Genet. 9:2001;130-134
31. Hosking L., et al. Detection of genotyping errors by Hardy-Weinberg equilibrium testing. Eur. J. Hum. Genet. 12:2004;395-399
32. Hopkins A.L., Groom C.R. The druggable genome. Nat. Rev. Drug Discov. 1:2002;727-730
33. Fredriksson R., et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63:2003;1256-1272
34. Conklin D., et al. Mining of assembled expressed sequence tag (EST) data for protein families: application to the G protein-coupled receptor superfamily. Brief. Bioinform. 1:2000;93-99
35. Vassilatis D.K., et al. The G protein-coupled receptor repertoires of human and mouse. Proc. Natl. Acad. Sci. U.S.A. 100:2003;4903-4908
36. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517
37. Carlson C.S., et al. Mapping complex disease loci in whole-genome association studies. Nature. 429:2004;446-452
38. Stoll M., et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat. Genet. 36:2004;476-480
39. Peltekova V.D., et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36:2004;471-475
40. Van Eerdewegh P., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 418:2002;426-430
41. Zhang Y., et al. Positional cloning of a quantitative trait locus on chromosome 13q14 that influences immunoglobulin E levels and asthma. Nat. Genet. 34:2003;181-186
42. Helms C., et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat. Genet. 35:2003;349-356
43. Altshuler D., et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat. Genet. 26:2000;76-80
44. Deeb S.S., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20:1998;284-287
45. Gloyn A.L., et al. Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes. 52:2003;568-572
46. Walley A.J., et al. Gene polymorphism in Netherton and common atopic disease. Nat. Genet. 29:2001;175-178
47. Begovitch A.B., et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet. 75:2004;330-337
48. Lander E.S. The new genomics: global views of biology. Science. 274:1996;536-539
49. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17:2001;502-510
50. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 69:2001;124-137